|
|
| (32 intermediate revisions by 10 users not shown) |
| Line 1: |
Line 1: |
| | __NOTOC__ |
| | {| class="infobox" style="float:right;" |
| | |- |
| | | [[File:Siren.gif|30px|link=Acute respiratory distress syndrome resident survival guide]]|| <br> || <br> |
| | | [[Acute respiratory distress syndrome resident survival guide|'''Resident'''<br>'''Survival'''<br>'''Guide''']] |
| | |} |
| | '''For patient information, click [[{{PAGENAME}} (patient information)|here]].''' |
| {{DiseaseDisorder infobox | | | {{DiseaseDisorder infobox | |
| Name = Acute respiratory distress syndrome | | | Name = Acute respiratory distress syndrome | |
| Line 5: |
Line 12: |
| ICDO = | | | ICDO = | |
| Image = Noncardiogenic pulmonary edema.JPG| | | Image = Noncardiogenic pulmonary edema.JPG| |
| Caption = [[Chest x-ray]] of patient wtih ARDS| | | Caption = [[Chest x-ray]] of patient with ARDS| |
| OMIM = | | | OMIM = | |
| MedlinePlus = 000103 | | | MedlinePlus = | |
| eMedicineSubj = med |
| |
| eMedicineTopic = 70 |
| |
| DiseasesDB = 892 | | | DiseasesDB = 892 | |
| }} | | }} |
| | {{Acute respiratory distress syndrome}} |
| | {{CMG}}; {{AE}} {{BShaller}} |
|
| |
|
| {{SI}} | | {{SK}} ARDS; adult respiratory distress syndrome; shock lung; Da Nang lung |
| {{CMG}}
| |
|
| |
|
| {{Editor Help}}
| | ==[[Acute respiratory distress syndrome overview|Overview]]== |
|
| |
|
| ==Overview== | | ==[[Acute respiratory distress syndrome historical perspective|Historical Perspective]]== |
|
| |
|
| '''Acute respiratory distress syndrome''' ('''ARDS'''), also known as '''respiratory distress syndrome''' ('''RDS''') or '''adult respiratory distress syndrome''' (in contrast with [[infant respiratory distress syndrome|IRDS]]) is a serious reaction to various forms of injuries to the [[lung]]. This is the most important disorder resulting in increased permeability [[pulmonary edema]].
| | ==[[Acute respiratory distress syndrome classification|Classification]]== |
|
| |
|
| ARDS is a severe [[lung]] disease caused by a variety of direct and indirect insults. It is characterized by [[inflammation]] of the lung [[parenchyma]] leading to impaired [[gas exchange]] with concomitant systemic release of inflammatory mediators causing [[inflammation]], [[Hypoxia (medical)|hypoxemia]] and frequently resulting in [[multiple organ failure]]. This condition is life threatening and often lethal, usually requiring [[mechanical ventilation]] and admission to an [[intensive care unit]]. A less severe form is called acute lung injury ('''ALI''').
| | ==[[Acute respiratory distress syndrome pathophysiology|Pathophysiology]]== |
|
| |
|
| ARDS formerly most commonly signified ''adult respiratory distress syndrome'' to differentiate it from [[infant respiratory distress syndrome]] in premature infants. However, as this type of pulmonary edema also occurs in children, ''ARDS'' has gradually shifted to mean ''acute'' rather than ''adult''. The differences with the typical infant syndrome remain.
| | ==[[Acute respiratory distress syndrome causes|Causes]]== |
|
| |
|
| ==Epidemiology== | | ==[[Acute respiratory distress syndrome differential diagnosis|Differentiating Acute respiratory distress syndrome from other Diseases]]== |
|
| |
|
| The annual incidence of ARDS is between 1.5 to 13.5 people per 100,000 in the general population. Its incidence in the [[intensive care unit]] (ICU), [[mechanical ventilation|mechanically ventilated]] population is much higher. Brun-Buisson ''et al.'' (2004) reported a prevalence of acute lung injury (ALI) (see below) of 16.1% percent in ventilated patients admitted for more than 4 hours. More than half these patients may develop ARDS.
| | ==[[Acute respiratory distress syndrome epidemiology and demographics|Epidemiology and demographics]]== |
|
| |
|
| [[Mechanical ventilation]], [[sepsis]], [[pneumonia]], [[Shock (medical)|shock]], [[Pulmonary aspiration|aspiration]], [[Physical trauma|trauma]] (especially pulmonary contusion), [[surgery|major surgery]], massive [[blood transfusion|transfusions]], [[smoke inhalation]], drug reaction or [[overdose]], [[fat emboli]] and reperfusion pulmonary edema after [[lung transplantation]] or pulmonary embolectomy may all trigger ARDS. Pneumonia and sepsis are the most common triggers, and pneumonia is present in up to 60% of patients. Pneumonia and sepsis may be either causes or complications of ARDS. | | ==[[Acute respiratory distress syndrome risk factors|Risk Factors]]== |
|
| |
|
| Elevated abdominal pressure of any cause is also probably a risk factor for the development of ARDS, particularly during mechanical ventilation.
| | ==[[Acute respiratory distress syndrome screening|Screening]]== |
|
| |
|
| Mortality varies from 30% to 60%. Usually, [[randomized controlled trials]] in the literature show lower death rates, both in control and treatment patients. This is thought to be due to stricter enrollment criteria. Observational studies generally report 50%-60% mortality.
| | ==[[Acute respiratory distress syndrome natural history, complications, and prognosis|Natural History, Complications, and Prognosis]]== |
|
| |
|
| == Definition == | | ==Diagnosis== |
| | | [[Acute respiratory distress syndrome diagnostic criteria|Diagnostic Criteria]] | [[Acute respiratory distress syndrome history and symptoms|History and Symptoms]] | [[Acute respiratory distress syndrome physical examination|Physical Examination]] | [[Acute respiratory distress syndrome laboratory tests|Laboratory Findings]] | [[Acute respiratory distress syndrome electrocardiogram | Electrocardiogram]] | [[Acute respiratory distress syndrome chest x ray|Chest X Ray]] | [[Acute respiratory distress syndrome CT|CT]] | [[Acute respiratory distress syndrome echocardiography|Echocardiography]] | [[Acute respiratory distress syndrome other imaging findings|Other Imaging Findings]] | [[Acute respiratory distress syndrome other diagnostic studies|Other Diagnostic Studies]] |
| ===''Historical background''===
| |
| | |
| Acute respiratory distress syndrome was first described in 1967 by Ashbaugh ''et al''.<ref name=Ashbaugh-ARDS>{{cite journal | author = Ashbaugh D, Bigelow D, Petty T, Levine B | title = Acute respiratory distress in adults. | journal = Lancet | volume = 2 | issue = 7511 | pages = 319-23 | year = 1967 | id = PMID 4143721}}</ref> Initially there was no definition, resulting in controversy over [[incidence]] and [[death|mortality]]. In 1988 an expanded definition was proposed which quantified physiologic respiratory impairment. | |
| | |
| In 1994 a new definition was recommended by the American-European Consensus Conference Committee.<ref name=definition-ARDS>{{cite journal | author = Bernard G, Artigas A, Brigham K, Carlet J, Falke K, Hudson L, Lamy M, Legall J, Morris A, Spragg R | title = The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. | journal = Am J Respir Crit Care Med | volume = 149 | issue = 3 Pt 1 | pages = 818-24 | year = 1994 | id = PMID 7509706}}</ref> It had two advantages: 1 it recognizes that severity of pulmonary injury varies, 2 it is simple to use.<ref name=Review-ARDS>{{cite journal | author = Ware L, Matthay M | title = The acute respiratory distress syndrome. | journal = N Engl J Med | volume = 342 | issue = 18 | pages = 1334-49 | year = 2000 | id = PMID 10793167}}</ref>
| |
| | |
| ARDS was defined as the ratio of arterial partial oxygen tension (PaO<sub>2</sub>) as fraction of inspired oxygen (FiO<sub>2</sub>) below 200 mmHg in the presence of bilateral alveolar infiltrates on the chest x-ray. These infiltrates may appear similar to those of left ventricular failure, but the cardiac silhouette appears normal in ARDS. Also, the pulmonary capillary wedge pressure is normal (less than 18 mmHg) in ARDS, but raised in left ventricular failure.
| |
| | |
| A PaO<sub>2</sub>/FiO<sub>2</sub> ratio less than 300 mmHg with bilateral infiltrates indicates acute lung injury (ALI). Although formally considered different from ARDS, ALI is usually just a precursor to ARDS.
| |
| | |
| ===''Consensus after 1967 and 1994''===
| |
| | |
| ARDS is characterized by:<ref name=definition-ARDS />
| |
| | |
| * Acute onset
| |
| * Bilateral infiltrates on chest radiograph
| |
| * Pulmonary artery wedge pressure < 18 mmHg (obtained by [[pulmonary artery catheter]]ization), if this information is available; if unavailable, then lack of clinical evidence of left ventricular failure suffices
| |
| * if PaO<sub>2</sub>:FiO<sub>2</sub> < 300 mmHg acute lung injury (ALI) is considered to be present
| |
| * if PaO<sub>2</sub>:FiO<sub>2</sub> < 200 mmHg acute respiratory distress syndrome (ARDS) is considered to be present
| |
| | |
| ==Patient presentation and diagnosis==
| |
| | |
| ARDS usually occurs within 24 to 48 hours of the initial injury or illness. The patient usually presents with [[shortness of breath]], [[tachypnea]], and symptoms related to the underlying cause, i.e. [[Shock (medical)|shock]].
| |
| | |
| An [[arterial blood gas]] analysis and [[chest X-ray]] allow formal diagnosis by inference using the aforementioned criteria. Although severe hypoxemia is generally included, the appropriate threshold defining abnormal PaO<sub>2</sub> has never been systematically studied.
| |
| | |
| Any cardiogenic cause of pulmonary edema should be excluded. This can be done by placing a [[pulmonary artery catheter]] for measuring the pulmonary artery wedge pressure. However, this is not necessary and is now rarely done as abundant evidence has emerged demonstrating that the use of pulmonary artery catheters does not lead to improved patient outcomes in critical illness including ARDS.
| |
| | |
| While CT scanning leads to more accurate images of the pulmonary parenchyma in ARDS, its has little utility in the clinical management of patients with ARDS, and remains largely a research tool. Plain Chest X-rays are sufficient to document bilateral alveolar infiltrates in the majority of cases.
| |
| | |
| ==Pathophysiology==
| |
| [[Image:ARDS.jpg|thumb|A pathohistological image of ARDS.]]
| |
| | |
| ARDS is characterized by a diffuse inflammation of lung parenchyma. The triggering insult to the parenchyma usually results in an initial release of [[cytokines]] and other inflammatory mediators, secreted by local [[epithelium|epithelial]] and [[endothelium|endothelial]] [[cell (biology)|cell]]s.
| |
| | |
| [[Neutrophils]] and some T-[[lymphocytes]] quickly migrate into the inflamed lung parynchema and contribute in the amplification of the phenomenon. | |
| | |
| Typical histological presentation involves diffuse [[Pulmonary alveolus|alveolar]] damage and [[hyaline]] membrane formation in alveolar walls.
| |
| | |
| Although the triggering mechanisms are not completely understood, recent research has examined the role of inflammation and mechanical stress.
| |
| | |
| ===Inflammation===
| |
| | |
| Inflammation alone, as in sepsis, causes endothelial dysfunction, fluid extravasation from the [[capillary|capillaries]] and impaired drainage of fluid from the lungs. Dysfunction of type II pulmonary epithelial cells may also be present, with a concomitant reduction in surfactant production. Elevated inspired oxygen concentration often becomes necessary at this stage, and they may facilitate a '[[respiratory burst]]' in immune cells.
| |
| | |
| In a secondary phase, endothelial dysfunction causes cells and inflammatory exudate to enter the alveoli. This [[pulmonary edema]] increases the thickness of the alveolo-capillary space, increasing the distance the [[oxygen]] must diffuse to reach [[blood]]. This impairs gas exchange leading to hypoxia, increases the work of breathing, eventually induces [[fibrosis]] of the airspace.
| |
| | |
| Moreover, edema and decreased surfactant production by type II pneumocytes may cause whole [[Pulmonary alveolus|alveoli]] to collapse, or to completely flood. This ''loss of aeration'' contributes further to the right-to-left [[shunt]] in ARDS. As the alveoli contain progressively less gas, more blood flows through them without being oxygenated resulting in massive intrapulmonary shunting.
| |
| | |
| Collapsed alveoli (and small [[bronchi]]) do not allow gas exchange. It is not uncommon to see patients with a PaO<sub>2</sub> of 60 mmHg (8.0 kPa) despite mechanical ventilation with 100% inspired oxygen.
| |
| | |
| The loss of aeration may follow different patterns according to the nature of the underlying disease, and other factors. In pneumonia-induced ARDS, for example, large, more commonly causes relatively compact areas of alveolar infiltrates. These are usually distributed to the lower [[lobe]]s, in their posterior segments, and they roughly correspond to the initial infected area.
| |
| | |
| In sepsis or trauma-induced ARDS, infiltrates are usually more patchy and diffuse. The posterior and basal segments are always more affected, but the distribution is even less homogeneous.
| |
| | |
| Loss of aeration also causes important changes in lung mechanical properties. These alterations are fundamental in the process of inflammation amplification and progression to ARDS in mechanically ventilated patients.
| |
| | |
| ===Mechanical stress===
| |
| | |
| [[Mechanical ventilation]] is an essential part of the treatment of ARDS. As loss of aeration (and the underlying disease) progress, the work of breathing (WOB) eventually grows to a level incompatible with life. Thus, mechanical ventilation is initiated to relieve respiratory muscles of their work, and to protect the usually obtunded patient's [[airway]]s.
| |
| | |
| However, mechanical ventilation may constitute a risk factor for the development, or the worsening, of ARDS.
| |
| | |
| Aside from the infectious complications arising from invasive ventilation with tracheal [[intubation]], positive-pressure ventilation directly alters lung mechanics during ARDS. The result is higher mortality, when injudicious techniques are used.
| |
| | |
| In 1998, Amato ''et al'' published a paper showing substantial improvement in the outcome of patients ventilated with lower tidal volumes (''V''<sub>t</sub>) (6 mL·kg<sup>-1</sup>).<ref name=Amato_1998>{{cite journal | author = Amato M, Barbas C, Medeiros D, Magaldi R, Schettino G, Lorenzi-Filho G, Kairalla R, Deheinzelin D, Munoz C, Oliveira R, Takagaki T, Carvalho C | title = Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. | journal = N Engl J Med | volume = 338 | issue = 6 | pages = 347-54 | year = 1998 | id = PMID 9449727}}</ref> This result was confirmed in a 2000 study sponsored by the [[National Institutes of Health|NIH]].<ref name=MacIntyre_2000>{{cite journal | author = MacIntyre N | title = Mechanical ventilation strategies for lung protection. | journal = Semin Respir Crit Care Med | volume = 21 | issue = 3 | pages = 215-22 | year = 2000 | id = PMID 16088734}}</ref> Although both these studies were widely criticized for several reasons, and although the authors were not the first to experiment lower-volume ventilation, they shed new light on the relationship between mechanical ventilation and ARDS.
| |
| | |
| One opinion is that the forces applied to the lung by the [[ventilator]] may work as a lever to induce further damage to lung parenchyma. It appears that shear stress at the [[Interface (chemistry)|interface]] between collapsed and aerated units may result in the breakdown of aerated units, which inflate asymmetrically due to the 'stickiness' of surrounding flooded alveoli. The fewer such interfaces around an alveolus, the lesser the stress.
| |
| | |
| Indeed, even relatively low stress forces may induce [[signal transduction]] systems at the cellular level, thus inducing the release of inflammatory mediators.
| |
| | |
| This form of stress is thought to be applied by the [[transpulmonary pressure]] (gradient) (''P''<sub>l</sub>) generated by the ventilator or, better, its cyclical variations. The better outcome obtained in patients ventilated with lower ''V''<sub>t</sub> may be interpreted as a beneficial effect of the lower ''P''<sub>l</sub>. [[Transpulmonary pressure|transpulmonary pressure]], is an indirect function of the ''V''<sub>t</sub> setting on the ventilator, and only trial patients with plateau pressures (a surrogate for the actual ''P''<sub>l</sub>) were less than 32 cmH<sub>2</sub>O]] (3.1 kPa had improved survival.
| |
| | |
| The way ''P''<sub>l</sub> is applied on alveolar surface determines the shear stress to which lung units are exposed. ARDS is characterized by an usually inhomogeneous reduction of the airspace, and thus by a tendency towards higher ''P''<sub>l</sub> at the same ''V''<sub>t</sub>, and towards ''higher'' stress on ''less'' diseased units.
| |
| | |
| The inhomogeneity of alveoli at different stages of disease is further increased by the gravitational gradient to which they are exposed, and the different perfusion pressures at which blood flows through them. Finally, abdominal pressure exerts an additional pressure on inferoposterior lung segments, favoring compression and collapse of those units.
| |
| | |
| The different mechanical properties of alveoli in ARDS may be interpreted as having varying ''time constants'' (the product of alveolar [[compliance]] × [[pulmonary alveolus#details|resistance]]). A long time constant indicates an alveolus which opens slowly during tidal inflation, as a consequence of contrasting pressure around it, or altered water-air interface inside it (loss of surfactant, flooding).
| |
| | |
| Slow alveoli are said to be 'kept open' using [[mechanical ventilation|positive end-expiratory pressure]], a feature of modern ventilators which maintains a positive airway pressure throughout the whole respiratory cycle. A higher mean pressure cycle-wide slows the collapse of diseased units, but it has to be weighed against the corresponding elevation in ''P''<sub>l</sub>/plateau pressure.
| |
| | |
| The prone position also reduces the inhomogeneity in alveolar time constants induced gravity and edema.
| |
| | |
| ===Progression===
| |
| | |
| If the underlying disease or injurious factor is not removed, the amount of inflammatory mediators released by the lungs in ARDS may result in a [[systemic inflammatory response syndrome]] (or sepsis if there is lung infection). The evolution towards [[Shock (medical)|shock]] and/or [[multiple organ failure]] follows paths analogous to the pathophysiology of sepsis.
| |
| | |
| This adds up to the impaired oxygenation, the real mainstay of ARDS, and [[respiratory acidosis]], often caused by the ventilation techniques indicated in ARDS.
| |
| | |
| The result is a critical illness in which the 'endothelial disease' of severe sepsis/SIRS is worsened by the pulmonary dysfunction, which further impairs oxygen delivery.
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| ===General===
| | [[Acute respiratory distress syndrome medical therapy|Medical Therapy]] | [[Acute respiratory distress syndrome mechanical ventilation therapy|Mechanical Ventilation Therapy]] | [[Acute respiratory distress syndrome secondary prevention|Secondary Prevention]] | [[Acute respiratory distress syndrome cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute respiratory distress syndrome future or investigational therapies|Future or Investigational Therapies]] |
| Acute respiratory distress syndrome is usually treated with mechanical ventilation in the Intensive Care Unit. Ventilation is usually delivered through oro-tracheal intubation, or tracheostomy whenever prolonged ventilation (≥2 weeks) is deemed inevitable. | |
| | |
| The possibilities of non-invasive ventilation are limited to the very early period of the disease or, better, to prevention in individuals at risk for the development of the disease ([[atypical pneumonia]]s, pulmonary contusion, major surgery patients).
| |
| | |
| Treatment of the underlying cause is imperative, as it tends to maintain the ARDS picture.
| |
| | |
| Appropriate [[antibiotic]] therapy must be administered as soon as [[microbiological culture]] results are available. Empirical therapy ''may'' be appropriate if local microbiological surveillance is efficient. More than 60% ARDS patients experience a (nosocomial) pulmonary infection either before or after the onset of lung injury.
| |
| | |
| The origin of [[infection]], when surgically treatable, must be operated on. When [[sepsis]] is diagnosed, appropriate local medical protocols should be enacted.
| |
| | |
| Commonly used supportive therapy includes particular techniques of mechanical ventilation and pharmacological agents whose effectiveness with respect to the outcome has not yet been proven. It is now debated whether mechanical ventilation is to be considered mere supportive therapy or actual treatment, since it may substantially affect survival.
| |
| | |
| ===Mechanical ventilation===
| |
| {{ Further|[[Pressure Regulated Volume Control]] }}
| |
| The overall goal is to maintain acceptable gas exchange and to minimize adverse effects in its application. Three parameters are used: PEEP (positive end-expiratory pressure, to maintain maximal recruitment of alveolar units), mean airway pressure (to promote recruitment and predictor of hemodynamic effects) and plateau pressure (best predictor of alveolar overdistention). <ref>{{cite journal | author =Malhotra A | title = Low-tidal-volume ventilation in the acute respiratory distress syndrome | journal = N Engl J Med | volume = 357 | issue = 11 | pages = 1113-20| year = 2007 | id = PMID 17855672 }}</ref>
| |
| | |
| Conventional therapy aimed at tidal volumes (''V''<sub>t</sub>) of 12-15 ml/kg. Recent studies have shown that high tidal volumes can overstretch alveoli resulting in volutrauma (secondary lung injury). The ARDS Clinical Network, or [http://www.ardsnet.org/index.php ARDSNet], completed a landmark trial that showed improved [[Mortality rate|mortality]] when ventilated with a tidal volume of 6 ml/kg compared to the traditional 12 ml/kg. Low tidal volumes (''V''<sub>t</sub>) may cause [[hypercapnia]] and [[atelectasis]].<ref name=Rippe-ARDS>{{cite book | author = Irwin RS, Rippe JM | title = Irwin and Rippe's Intensive Care Medicine | edition = 5th ed. | publisher = Lippincott Williams & Wilkins | year = 2003 | id = ISBN 0-7817-3548-3 }}</ref>
| |
| | |
| Low tidal volume ventilation was the primary independent variable associated with reduced mortality in the NIH-sponsored ARDSnet trial of tidal volume in ARDS. Plateau pressure less than 30 cm H2O was a secondary goal, and subsequent analyses of the data from the ARDSnet trial (as well as other experimental data) demonsrtate that there appears to be NO safe upper limit to plateau pressure; that is, regardless of plateau pressure, patients fare better with low tidal volumes (see Hager et al, American Journal of Respiratory and Critical Care Medicine, 2005).
| |
| | |
| === APRV (Airway Pressure Release Ventilation) and ARDS / ALI===
| |
| | |
| Although a particular ventilation mode has yet to be "proven in clinical trials"* more effective than others in treating patients with ARDS, ever increasing empirical evidence and clinical experience is showing that [http://www.aacn.org/pdfLibra.NSF/Files/ci120205/$file/ci120205.pdf APRV]is the primary mode of choice when ventilating a patient with ARDS or ALI (Acute Lung Injury).
| |
| | |
| Advantages to APRV ventilation include: decreased airway pressures, decreased minute ventilation, decreased dead-space ventilation, promotion of spontaneous breathing, almost 24 hour a day alveolar recruitment, decreased use of sedation, near elimination of neuromuscular blockade and an often positive effect on cardiac output (due to the negative inflection from the elevated baseline with each spontaneous breath).
| |
| | |
| A patient with ARDS on average spends 8 to 11 days on a mechanical ventilator; APRV may reduce this time significantly.
| |
| | |
| * *This would require a side by side study of APRV and the current ARDSNet protocol. There seems to be little political will, within the medical community, to address the need for this study, in spite of the successes seen with APRV.
| |
| | |
| === Positive end-expiratory pressure ===
| |
| [[Positive end-expiratory pressure]] (PEEP) must be used in mechanically-ventilated patients in order to contrast the tendency to collapse of affected alveoli.
| |
| | |
| Ideally, a 'perfect' PEEP would match the increased alveolar [[surface tension]], caused by surfactant deficiency and external pressure (edema), thus restoring a normal time constant in all affected units.
| |
| | |
| However, because of the cited inherent inhomogeneity, surface tension varies, and so do PEEP requirements for the diseased units. Furthermore, high levels of PEEP may impair [[venous blood]] return to the right [[heart]], although the actual impact of PEEP on [[hemodynamics]] is still debated.
| |
| | |
| The 'best PEEP' used to be defined as 'some' cmH<sub>2</sub>O above the lower inflection point (LIP) in the sigmoidal pressure-volume relationship curve of the lung. Recent research has shown that the LIP-point pressure is no better than any pressure above it, as recruitment of collapsed alveoli, and more importantly the overdistention of aerated units, occur throughout the whole inflation. Despite the awkwardness of most procedures used to trace the pressure-volume curve, it is still used by some to define the ''minimum'' PEEP to be applied to their patients. Some of the newest ventilators have the ability to automatically plot a pressure-volume curve. The possibility of having an 'instantaneous' tracing trigger might produce renewed interest in this analysis.
| |
| | |
| PEEP may also be set empirically. Some authors suggest performing a 'recruiting maneuver' (i.e., a short time at a very high continuous positive airway pressure, such as 50 cmH<sub>2</sub>O (4.9 kPa), to recruit, or open, collapsed unit with a high distending pressure) and then to increase PEEP to a rather high level before restoring previous ventilation. The final PEEP level should be the one just before the drop in PaO<sub>2</sub> (or [[hemoglobin|peripheral blood oxygen saturation]]) during a step-down trial.
| |
| | |
| PEEP 'stacks up' to P<sub>l</sub> during volume-controlled ventilation. At high levels, it may cause significant overdistension of (and injury to) compliant, aerated units, and higher plateau pressures at the same ''V''<sub>t</sub>.
| |
| | |
| Intrinsic positive end-expiratory pressure (Intrinsic PEEP, iPEEP) or auto-PEEP, is not detected during normal ventilation. However, when ventilating at high frequencies, its contribution may be substantial, both in its positive and negative effects. There are 'underground', unproven claims that the Amato and NIH/ARDS Network studies got a positive result because of the high iPEEP levels reached by spontaneously breathing patients in low-volume assist-control ventilation. Whether or not that is true, it is a fact that iPEEP has been measured in very few formal studies on ventilation in ARDS patients, and its entity is largely unknown. Its measurement is recommended in the treatment of ARDS patients, especially when using high-frequency (oscillatory/jet) ventilation.
| |
| | |
| A compromise between the beneficial and adverse effects of PEEP is, as usual, inevitable.
| |
| | |
| === Prone position ===
| |
| Distribution of lung infiltrates in acute respiratory distress syndrome is non-uniform. Repositioning into the prone position (face down) might improve oxygenation by relieving [[atelectasis]] and improving perfusion. However, although the hypoxemia is overcome there seems to be no effect on overall survival.<ref name=Prone-ARDS>{{cite journal | author = Gattinoni L, Tognoni G, Pesenti A, Taccone P, Mascheroni D, Labarta V, Malacrida R, Di Giulio P, Fumagalli R, Pelosi P, Brazzi L, Latini R | title = Effect of prone positioning on the survival of patients with acute respiratory failure. | journal = N Engl J Med | volume = 345 | issue = 8 | pages = 568-73 | year = 2001 | id = PMID 11529210}}</ref><ref name=Rippe-ARDS />
| |
| | |
| === Fluid management ===
| |
| Several studies have shown that pulmonary function and outcome are better in patients that lost weight or wedge pressure was lowered by [[diuresis]] or fluid restriction.<ref name=Rippe-ARDS />
| |
| | |
| === Corticosteroids ===
| |
| Patients with ARDS do not benefit from high-dose corticosteroids. Meduri et al however did find significant improvement using modest doses. This is probably because of a suppression of ongoing inflammation during the fibroproliferative phase of ARDS. The initial regimen consists of [[methylprednisolone]] 2 mg/kg daily. After 3-5 days a response must be apparent. In 1-2 weeks the dose can be tapered to methylprednisolone 0.5-1.0 mg daily. In the absence of results steroids can be discontinued.<ref name=Meduri-ARDS>{{cite journal | author = Meduri G, Tolley E, Chrousos G, Stentz F | title = Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. | journal = Am J Respir Crit Care Med | volume = 165 | issue = 7 | pages = 983-91 | year = 2002 | id = PMID 11934726}}</ref><ref name=Rippe-ARDS />
| |
| | |
| The recent NIH-sponsored ARDSnet LAZARUS study of corticosteroids for ARDS demonstrated that they are not efficacious in ARDS.
| |
| | |
| === Nitric oxide ===
| |
| Inhaled [[nitric oxide]] (NO) potentially acts as selective pulmonary vasodilator. Rapid binding to [[hemoglobin]] prevents systemic effects. It should increase perfusion of better ventilated areas. There are no large studies demonstrating positive results. Therefore its use must be considered individually.
| |
| | |
| Almitrine bismesylate stimulates chemoreceptors in carotic and aortic bodies. It has been used to potentiate the effect of NO, presumably by potentiating hypoxia-induced pulmonary vasoconstriction. In case of ARDS it is not known whether this combination is useful.<ref name=Rippe-ARDS />
| |
| | |
| === Surfactant therapy ===
| |
| To date no prospective [[Randomized controlled trial|controlled clinical trial]] has shown a significant mortality benefit of exogenous surfactant in ARDS.<ref name = Rippe-ARDS />
| |
| | |
| ==Complications==
| |
| Since ARDS is an extremely serious condition which requires invasive forms of therapy it is not without risk. Complications to be considered are:<ref name = Rippe-ARDS />
| |
| *Pulmonary: [[barotrauma]] (volutrauma), [[pulmonary embolism]] (PE), pulmonary fibrosis, [[ventilator-associated pneumonia]] (VAP).
| |
| *Gastrointestinal: hemorrhage (ulcer), dysmotility, pneumoperitoneum, bacterial translocation.
| |
| *Cardiac: arrhytmias, myocardial dysfunction.
| |
| *Renal: [[acute renal failure]] (ARF), positive fluid balance.
| |
| *Mechanical: vascular injury, pneumothorax (by placing pulmonary artery catheter), tracheal injury/stenosis (result of intubation and/or irritation by endotracheal tube.
| |
| *Nutritional: malnutrition (katabolic state), electrolyte deficiency.
| |
| | |
| ==References==
| |
| {{Reflist|2}}
| |
| | |
| ===Further reading===
| |
| <div class="references-small" style="-moz-column-count:2; column-count:2;">
| |
| | |
| * Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med. 2005 Aug;33(8):1681-1687. PMID 16096441.
| |
| * Jackson WL Jr, Shorr AF. Blood transfusion and the development of acute respiratory distress syndrome: more evidence that blood transfusion in the intensive care unit may not be benign. Crit Care Med. 2005 Jun;33(6):1420-1. PMID 15942365.
| |
| * [http://www.lww.com/product/?0-683-05565-8 The ICU Book by Marino]
| |
| | |
| </div>
| |
|
| |
|
| ==External links==
| |
| * [http://www.aafp.org/afp/20020501/1823.html Acute Respiratory Distress Syndrome - May 1, 2002 - American Family Physician]
| |
| * [http://rad.usuhs.mil/rad/chest_review/index.html Basic Chest X-Ray Review]
| |
| * [http://www.radiology.vcu.edu/2004%2004%2016%20cotw.htm Transfusion related acute lung injury (TRALI)]
| |
| * [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10193545&query_hl=62&itool=pubmed_docsum Antioxidant status in patients with acute respiratory distress syndrome.]
| |
| * [http://www.ardsnet.org/ ARDSNet] — the NIH / NHLBI ARDS Network
| |
| * [http://www.ards.org/ ARDS Support Center] — information and support for patients with ARDS and their loved ones
| |
|
| |
| {{Respiratory pathology}}
| |
| {{Intensive care medicine}}
| |
| {{SIB}}
| |
|
| |
| [[Category:Causes of death]]
| |
| [[Category:Intensive care medicine]]
| |
| [[Category:Pulmonology]] | | [[Category:Pulmonology]] |
| [[Category:Syndromes]]
| |
|
| |
| [[de:Acute Respiratory Distress Syndrome]]
| |
| [[es:Síndrome de distrés respiratorio agudo]]
| |
| [[fr:Syndrome de détresse respiratoire aiguë]]
| |
| [[nl:ARDS]]
| |
| [[ja:急性呼吸窮迫症候群]]
| |
| [[pl:Zespół ostrej niewydolności oddechowej]]
| |
| [[pt:Síndrome do desconforto respiratório do adulto]]
| |
| [[fi:Äkillinen hengitysvaikeusoireyhtymä]]
| |
| [[sv:Adult respiratory distress syndrome]]
| |
| [[zh:成人呼吸窘迫症候群]]
| |
|
| |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
